Skip to main content
MEDINET Co., Ltd. logo

MEDINET Co., Ltd. — Investor Relations & Filings

Ticker · 2370 ISIN · JP3920990003 T Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2016-05-12 Interim / Quarterly Rep…
Country JP Japan
Listing T 2370

About MEDINET Co., Ltd.

https://www.medinet-inc.co.jp/english/

MEDINET Co., Ltd. is a Contract Development and Manufacturing Organization (CDMO) specializing in regenerative medicine and cell therapy. The company provides comprehensive, one-stop solutions across the entire value chain, from pre-clinical research and process development to manufacturing and commercial launch. Its services encompass technology transfer, quality control, and quality assurance for regenerative medical products, investigational products, and specified cell products. MEDINET operates an advanced cell processing facility (CPF) designed to comply with international standards such as GCTP, leveraging extensive experience since 1999 to support clients in developing and manufacturing their cellular therapies.

Recent filings

Filing Released Lang Actions
四半期報告書－第21期第2四半期(2016/01/01－2016/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the company MEDINET Co., Ltd. It contains detailed financial statements, including the balance sheet, income statement, and cash flow analysis for the second quarter of the fiscal year ending March 31, 2016. It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2016
2016-05-12 Japanese
四半期報告書－第21期第1四半期(2015/10/01－2015/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 21st fiscal period of MEDINET Co., Ltd., covering the period from October 1, 2015, to December 31, 2015. It contains detailed financial statements, management analysis of financial conditions, and business performance, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-02-12 Japanese
訂正有価証券報告書－第20期(2014/10/01－2015/09/30)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (訂正有価証券報告書) for an Annual Securities Report (有価証券報告書). In the Japanese regulatory context, the '有価証券報告書' is the equivalent of the US 10-K, serving as the comprehensive annual financial report. Since this is a correction to that filing, it falls under the 10-K category as it pertains to the annual financial disclosure. FY 2015
2015-12-25 Japanese
有価証券報告書－第20期(2014/10/01－2015/09/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management discussion, and business information for the fiscal year ending September 30, 2015. This corresponds to the definition of an Annual Report (10-K equivalent). FY 2015
2015-12-17 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.